NEW YORK, September 23, 2021 – Proskauer, a leading international law firm, is pleased to share that Managing Partner Daryn Grossman, and Partners Dr. Fangli Chen, Siegmund Gutman, and Bart Williams have been named as 2021 Life Sciences Stars by LMG Life Sciences. LMG Life Sciences is the only legal ranking directory that identifies the leading law firms and individuals in each practice area of the life sciences industry through deep analysis of the business and legal developments in the sector. Its annual ranking highlights firms and attorneys that effectively present the complexities surrounding the intersection of the legal market and life sciences industry.
Daryn, who is also head of the Life Sciences Group, was recognized for her work in the Licensing & Collaboration practice area. She has deep experience designing and negotiating complex technology and intellectual property transaction structures, including strategic alliances, licensing, and technology development and outsourcing transactions.
A partner in the Litigation Department and vice chair of the Life Sciences Patent Practice, Fangli, represents companies in numerous industries across the biotech and pharmaceutical sectors. This year, she was honored for her skill in the General Patent Litigation and Patent Strategy and Management practice areas. She specializes in the strategic development of complex IP portfolios for companies to align with their business goals.
Siegmund is chair of Proskauer’s Life Sciences Patent Practice, as well as a partner in the Litigation Department and a member of the Firm’s Patent Law and Intellectual Property Groups. He focuses his practice on developing and executing market exclusivity and freedom-to-operate strategies and has extensive experience successfully litigating biologic drug patent and Hatch-Waxman cases. Sige was recognized by LMG Life Sciences for his expertise in the General Patent Litigation practice area.
As one of the nation’s most sought after trial lawyers and commercial litigators, Bart has represented Fortune 500 corporations across a range of industries, including life sciences. He is a partner in the Firm’s Litigation Department and a go-to lawyer for cases involving product liability and white-collar and government investigations – two practice areas he earned recognition for in LGM Life Sciences’ annual ranking.
About Proskauer
We are 725+ lawyers serving clients from 12 offices located in the leading financial and business centers in the Americas, Europe and Asia. The world’s leading organizations, companies and corporations choose us to be their representatives in their most critical situations. But more, they consider Proskauer a strategic partner to drive their business forward. We work with asset managers, major sports leagues, Fortune 500 companies, entertainment industry legends and other industry-redefining companies.
Proskauer’s multidisciplinary Life Sciences Group brings together the critical skill sets and experience to litigate important intellectual property matters, create and grow life sciences companies, obtain intellectual property rights, raise capital and negotiate and execute strategic deals.
We represent mature pharma and biotech companies in accessing and protecting markets, early-to-later-stage companies in developing new medical technologies, investors in their strategic transactions, as well as universities and other academic or research institutions in realizing commercial value from the innovation of their faculty and research staff. The myriad connections we have in this sector allow us to help clients grow their businesses by gaining access to financing, technology, partners and markets. Working with clients at each stage of their development, our lawyers handle any challenges along the way. Whether raising capital, negotiating licensing agreements or terms of a sale or fighting back patent challenges, our team is equipped to help life sciences companies meet their business goals.